Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 18/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4316179 | 0.94 | CCR1 (0.43) | CCR1CYP2C19KCNH2 | |
| SCHEMBL4016493 | 0.89 | CCR1 (0.39) | CCR1CYP2C19KCNH2MAPT | |
| SCHEMBL4020846 | 0.87 | CCR1 (0.56) | CCR1CYP2C19KCNH2 | |
| SCHEMBL4304679 | 0.86 | CCR1 (0.48) | CCR1CYP2C19KCNH2 | |
| SCHEMBL4019925 | 0.84 | CCR1 (0.40) | CCR1CYP2C19KCNH2 | |
| SCHEMBL6170444 | 0.84 | CCR1 (0.42) | CCR1CYP2C19KCNH2 | |
| SCHEMBL4018406 | 0.83 | CCR1 (0.42) | CCR1CYP2C19KCNH2 | |
| SCHEMBL4565941 | 0.83 | CCR1 (0.55) | CCR1CYP2C19KCNH2 | |
| SCHEMBL6169622 | 0.83 | GAA (0.42) | CCR1CYP2C19KCNH2MAPT | |
| SCHEMBL4025793 | 0.83 | CCR1 (0.42) | CCR1CYP2C19KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1691810-A4 | SUBSTITUTED PIPERAZINES | CHEMOCENTRYX INC (US) | 2009-07-01 | — | — | EP | disclosed |
| EP-1691810-A1 | SUBSTITUTED PIPERAZINES | ChemoCentryx Inc (US) | 2006-08-23 | — | — | EP | disclosed |
| WO-2005056015-A1 | SUBSTITUTED PIPERAZINES | CHEMOCENTRYX, INC. (US) | 2005-06-23 | — | — | WO | disclosed |